Design of Potent and Selective In Vivo Antagonists of the Neurohypophysial Peptides
- 1 January 1983
- book chapter
- Published by Elsevier
- Vol. 60, 367-382
- https://doi.org/10.1016/s0079-6123(08)64404-0
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat.Hypertension, 1979
- [1-.beta.-Mercapto-.beta.,.beta.-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocinJournal of Medicinal Chemistry, 1975
- Synthesis and inhibitory properties of oxytocin analogues modified in the amino-terminal region of the moleculeCollection of Czechoslovak Chemical Communications, 1975
- Synthesis of three oxytocin analogs related to [1-deaminopenicillamine]oxytocin prossessing antioxytocic activityJournal of Medicinal Chemistry, 1972
- The syndrome of inappropriate secretion of antidiuretic hormoneThe American Journal of Medicine, 1967
- Solid Phase Peptide Synthesis. I. The Synthesis of a TetrapeptideJournal of the American Chemical Society, 1963
- Inhibition of the uterus-contracting effect of oxytocin by O-methyloxytocinCollection of Czechoslovak Chemical Communications, 1961
- Synthesis of 2-p-Methoxyphenylalanine Oxytocin (O-Methyl-oxytocin) and Some Observations on its Pharmacological Behavior1Journal of the American Chemical Society, 1960
- A SYNTHETIC PREPARATION POSSESSING BIOLOGICAL PROPERTIES ASSOCIATED WITH ARGININEVASOPRESSINJournal of the American Chemical Society, 1954
- The Synthesis of Oxytocin1Journal of the American Chemical Society, 1954